Sub-Saharan Africa (IDA & IBRD countries) vs Sweden: Access to anti-retroviral drugs, male
Sub-Saharan Africa (IDA & IBRD countries)
79.8%
in 2024
Sweden
95.0%
in 2022
Sub-Saharan Africa (IDA & IBRD countries) rank
7th
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Sub-Saharan Africa (IDA & IBRD countries)
- Sweden
How they compare
Sweden currently reports 95.0% against 79.8% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 15.2%.
That makes Sweden's figure about 1.2 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 23 years both countries report, Sweden has been ahead every year.
Sub-Saharan Africa (IDA & IBRD countries) ranks 7th and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sub-Saharan Africa (IDA & IBRD countries) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 53.7% | 48.0% | Sweden |
| 2010s | 42.2% | 92.5% | 50.3% | Sweden |
| 2020s | 70.1% | 95.3% | 25.3% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Sub-Saharan Africa (IDA & IBRD countries) or Sweden?
- Sweden, at 95.0% against 79.8% in Sub-Saharan Africa (IDA & IBRD countries) as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Sub-Saharan Africa (IDA & IBRD countries) and Sweden?
- 15.2%, with Sweden ahead.
- How many years of comparable data are there for Sub-Saharan Africa (IDA & IBRD countries) and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Sub-Saharan Africa (IDA & IBRD countries) and Sweden rank globally for access to anti-retroviral drugs, male?
- Sub-Saharan Africa (IDA & IBRD countries) ranks 7th and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.